Objective: To estimate new human immunodeficiency virus (HIV) diagnosis rates among HIV negative men who have sex with men (MSM) who are repeatedly tested for HIV in sexually transmitted disease (STD) clinics and assess the impact of demographic and disease-specific characteristics that are associated with higher HIV diagnosis rates.
Results: Overall, 640 HIV diagnoses occurred among 14,824 individuals and 20,951.6 PYof observation, for an adjusted incidence of HIV diagnosis of 3.0 per 100 PY (95% CI, 2.6-3.4). Rates varied across race/ethnicity groups with the highest rate among Blacks (4.7/100 PY; 95% CI, 4.1-5.3) followed by Hispanics, whites, and persons of other races/ethnicities. Men who have sex with men having a diagnosis of primary or secondary (P&S) syphilis on or after the first negative HIV test had a higher new HIV diagnosis rate (7.2/100 PY; 95% CI, 5.8-9.0) compared with MSM who did not have a P&S syphilis diagnosis (2.8/100 PY; 95% CI, 2.6-3.1). Men who have sex with men who tested positive for rectal gonorrhea (6.3/100 PY; 95% CI, 5.7-6.9) or rectal chlamydia (5.6/100 PY; 95% CI, 4.6-6.6) had higher rates of new HIV diagnosis when compared to those with negative test results.
Conclusions:
Men who have sex with men attending SSuN STD clinics have high rates of new HIV diagnoses, particularly those with a previous diagnosis of P&S syphilis, rectal chlamydia, and/or gonorrhea. Sexually transmitted disease clinics continue to be important clinical setting for diagnosing HIV among MSM populations.
T he high risk of human immunodeficiency virus (HIV) infection among gay, bisexual, and other men who have sex with men (MSM) (collectively referred to as MSM) in the United States remains a major public health crisis. Men who have sex with men make up a small proportion (~2%) of the US population. 1 Although the vast majority of MSM do not have HIV, 70% of diagnosed HIV infections were attributed to male-to-male sexual contact from 2010 to 2014. 2 The US Centers for Disease Control and Prevention (CDC) currently recommends that individuals at increased risk for HIV infection, including sexually active MSM, undergo HIV testing at least annually.
Yet despite efforts to promote routine HIV testing and decades of research dedicated to the prevention of HIV infection, there remains a substantial amount of new HIV infections annually.
Sexually transmitted disease (STD) clinics have historically been an important health care setting for clients who may not otherwise have access to health care services but are at high risk for HIV infection and unaware of their HIV status. The patients who seek treatment for STDs, including those attending STD clinics, should be screened routinely for HIV during each visit for a new complaint, regardless of whether the patient is known or suspected to have specific behavioral risks for HIV infection. 3 Additionally, STD clinics are relevant to men who may be less likely to seek preventive care and have a usual source of care compared with women. [4] [5] [6] As such, these can be critical settings to estimate the incidence of new HIV diagnoses among MSM, with the ultimate goal of informing prevention strategies. Comorbid infections with bacterial STDs may serve as risk markers for incident HIV infection, including previous bacterial STDs, as have been documented in multiple studies. [7] [8] [9] [10] [11] However, many of these published studies focused on a single jurisdiction, and a few were constrained by small sample sizes, limiting the ability to report estimates stratified by certain patient characteristics. This study retrospectively reviews the data collected on all MSM patients attending a network of US STD clinics with the goal of (1) documenting new HIV diagnosis rates among previously HIV uninfected individuals who are repeatedly tested for HIV and (2) assessing the impact of demographic and diseasespecific characteristics that may be associated with higher HIV diagnosis rates. Understanding these factors associated with a new HIV diagnosis will further enhance current understanding and development of more effective HIV prevention interventions for at-risk populations.
METHODS
We examined data from the STD Surveillance Network (SSuN), a sentinel surveillance system that includes 40 Person-years (PY) at risk were calculated from the date of the first negative HIV test to the date of the last HIV-negative test or to the first HIV-positive test divided by 365.25 days. The follow-up period for MSM that remained HIV-negative included the time between their first and last negative HIV tests. The follow-up period for MSM who were diagnosed with HIV included the time between the first negative and the first positive HIV test. We calculated jurisdiction-adjusted new HIV diagnosis rates using a 2-stage meta-analysis model to account for the substantial diversity in patients across the SSuN jurisdictions. First, HIV diagnosis rates per 100 PY were calculated as number of events of HIV diagnoses divided by PY at risk for a single jurisdiction, multiplied by 100. Then, using the jurisdiction-specific estimates, we estimated the overall rate with 95% confidence intervals (CI) using an inverse variance weighted random effects model, adjusting for heterogeneity between SSuN jurisdictions. We used this method to estimate new HIV diagnosis rates by the following: age group categories, race/ethnicity, SSuN jurisdiction, diagnosed chlamydia or gonorrhea (among those tested for chlamydia and/or gonorrhea in STD clinics, and stratified by anatomic site of infection), and diagnosed P&S syphilis during the follow-up period. Because time to HIV diagnosis may be impacted by testing frequency, which may be more frequent for MSM diagnosed with an STD, we estimated the mean number of clinic visits and testing visits by STD history. Analyses were conducted using SAS version 9.4 (SAS Institute, Cary, NC).
Although the objectives of the present analysis did not focus on other individuals attending SSuN STD clinics, we did examine HIV diagnoses rates among women and men who have sex with women (MSW) between January 1, 2010, and June 30, 2013, for comparison purposes only. The MSW were defined as men who only reported female sex partners or who identified as heterosexual and who did not report any male sex partners. Similar methods were used to assess new HIV diagnoses as described above.
Data from participating jurisdictions were collected as part of CDC sentinel surveillance activities exempt from CDC human subjects review; SSuN protocols were approved by the Office of Management and Budget (control 0920-0842 and 0920-1072) and did not include personal identifiers on individual patients.
RESULTS
Between January 1, 2010, and June 30, 2013, there were 138,999 patient visits made by 55,266 unique MSM across the 40 STD clinics (Fig. 1 ). Among the MSM tested for HIV at least once (n = 38,915), 14,824 had a visit with a negative HIV test result followed by at least 1 other visit where an HIV test was performed. This group of 14,824 MSM, described in Table 1 , represents 26.9% of all 55,266 MSM seen in SSuN STD clinics and is the focus of all subsequent analyses. These 14,824 MSM were similar to the MSM who were tested for HIV only once (n = 24,091) with regard to age, but the group of 14,824 MSM were marginally more likely to be black (24% vs 20%, P > .05) and/or Hispanic (27% vs 23%; P > .05). Differences in the number of MSM (n = 14,824) varied across jurisdictions, with the majority (56%) of MSM seen in STD clinics in New York City and San Francisco. The median age of the included MSM was 29.0 years (interquartile range [IQR], 25-37 years). Among 14,824 MSM who were tested for HIV at least twice (median, 3 HIV tests; IQR, 2-4 HIV tests), 640 (4.3%) subsequently tested positive for HIV (Table 1) . These 14,824 MSM contributed 20,951.6 PY of follow-up time. After adjusting for SSuN jurisdictions, the overall new HIV diagnosis rate was 3.0 per 100 PY (95% CI, 2.6-3.4). For those MSM who were diagnosed with HIV, the median time between the first HIV-negative and first Figure 1 . Selection of the study population.
HIV-positive test was 1.2 years (IQR, 231 days to 1.9 years). For the patients who remained HIV-negative, the median follow-up time was 1.3 years (IQR, 230 days to 2.1 years). New HIV diagnosis rates varied by jurisdiction and was lowest in New Haven/Hartford (0.7/100 PY; 95% CI 0.1-5.1) and highest in New Orleans (8.2/100 PY; 95% CI, 5.6-12.1).
Rates of new HIV diagnoses among MSM varied across the race/ethnicity groups with the highest rate among blacks (4.7/100 PY; 95% CI, 4.1-5.3) followed by Hispanics, whites, and persons of other races and ethnicities (Table 1) . New HIV diagnosis rates declined as age increased; the diagnosis rate among MSM aged 19 years or younger was over 4 times that among MSM older than 50 years. When stratified by race, new HIV diagnosis rates were significantly higher among black MSM younger than 25 years (7.2/100 PY; 95% CI, 6.1-8.3) compared with their white (4.3/100 PY; 95% CI: 3.5-5.1) and Hispanic counterparts (3.6/100 PY; 95% CI, 2.6-4.6) (Fig. 2) .
The mean number of clinic visits during the observation period for the MSM without STDs and with STDs diagnosed were 5.3 and 6.8 (P < 0.05), respectively. The mean number of HIV testing visits during the observation period for the MSM without STDs and with STDs diagnosed were 2.7 and 3.3 (P < 0.05), respectively. A statistically significantly higher HIV diagnosis rate was observed among MSM with a STD diagnosis (4.1; 95% CI, 3.6-4.6) compared with those MSM not diagnosed with STD (2.0; 95% CI, 1.7-2.3).
We estimated the adjusted rates of new HIV diagnosis by specific STD diagnosis during the follow-up period (Table 1) . Overall, MSM who had a diagnosis of P&S syphilis on or after the first negative HIV test had a higher new HIV diagnosis rate (7.2/100 PY; 95% CI, 6.0-8.4) compared with MSM who did not have a P&S syphilis diagnosis (2.7/100 PY; 95% CI, 2.3-3.1). Similarly, MSM who tested positive for gonorrhea (4.0/100 PY; 95% CI, 3.5-4.5) or chlamydia (2.8/100 PY; 95% CI, 2.2-3.4) had higher rates of new HIV diagnoses when compared with those with negative test results. Compared with MSM not diagnosed with rectal chlamydia or gonorrhea, MSM with 1 or more episodes of rectal chlamydia (5.6/100 PY; 95% CI, 4.6-6.6) or rectal gonorrhea (6.3/100 PY; 95% CI, 5.7-6.9) had higher rates of HIV diagnosis (Fig. 3 ). For MSM with P&S syphilis, the rate of HIV diagnosis for black MSM was 10.5 per 100 PY (95% CI, 8.9-11.6) (Fig. 4) . This was significantly different from that of whites but not Hispanics. Additionally, blacks New HIV Diagnoses Among MSM Sexually Transmitted Diseases • Volume 45, Number 9, September 2018had significantly higher rates of HIV diagnoses if they were diagnosed with either rectal gonorrhea and/or chlamydia when compared with their Hispanic and white counterparts.
When HIV diagnosis rates among MSM were compared with heterosexual men and women, markedly higher MSM rates were observed in every SSuN jurisdiction. Sixty-nine new HIV diagnoses were identified in MSW with an adjusted HIV diagnosis rate of 0.12/100 PY (95% CI, 0.10-0.14) (range, 0.1-0.4 by SSuN jurisdiction). Sixty-six new HIV diagnoses were identified in women for an adjusted HIV diagnosis rate of 0.12/100 PY (CI 0.1-0.14) (range, 0.05-0.4 by SSuN jurisdiction).
DISCUSSION
Men who have sex with men are disproportionately affected by HIV, and STD clinics continue to be important clinical settings that provide HIV testing services to a large number of MSM. Among MSM tested at least twice for HIV in this network of STD clinics, we report an overall incidence of HIV diagnosis of 3.0 per 100 PY, with even greater rates observed among MSM diagnosed with rectal gonorrhea, rectal chlamydia, or P&S syphilis. Previous studies conducted in STD clinics have shown comparable HIV incidence rates with higher observed rates in patients with bacterial STDs, [11] [12] [13] [14] [15] [16] echoing the need to target HIV prevention interventions to these key affected populations of men.
Our estimates corroborate racial/ethnic and age disparities in HIV diagnosis rates that have been documented elsewhere by other investigators. 1, 2, [17] [18] [19] [20] In our analysis, the observed rate among black MSM (4.7 per 100 PY) was almost twice that of other race/ethnicities and young black MSM (≤24 years of age) had the highest rate (7.2 per 100 PY). The HIV diagnosis rates among blacks with P&S syphilis, rectal gonorrhea, and rectal chlamydia were notably higher than HIV diagnosis rates among other MSM without STD diagnoses. Several economic and sociocultural factors proposed to explain racial and ethnic disparities in risk for HIV include unemployment, poverty, lack of health insurance, issues with literacy and low education rates, barriers to testing, and higher HIV prevalence among some sexual networks. [21] [22] [23] A recent National HIV Behavioral Surveillance analysis by Wejnert et al 24 examined a 2008 to 2014 surveillance data from MSM from 20 cities and noted that black MSM have the highest HIV prevalence and the lowest awareness of their HIV infection, which was especially true for young black MSM. Young MSM of minority races and ethnicities could be targeted with prevention efforts that address their complex social needs as well as the structural barriers that increase their HIV risk, including targeted messaging about frequent HIV testing and expanding access to a variety of testing venues.
Given that an STD diagnosis may indicate HIV-related sexual risk behavior, targeting prevention efforts to MSM with a bacterial STD may identify those at greatest risk for HIV infection. However, of the 640 MSM identified with incident HIV diagnosis in our analysis, approximately 60% had a STD diagnosis in the SSuN STD clinics during the follow-up period. Concentrating prevention efforts on only those at the very highest risk, such as those who were diagnosed with P&S syphilis or rectal gonorrhea and/or chlamydia, will likely reach only a subset of the MSM who will ultimately acquire HIV infection. Also, although MSM who were not diagnosed with chlamydia, gonorrhea, or P&S syphilis in the SSuN STD clinics had a lower rate of HIV diagnosis of 2.0 per 100 PY, their rate of HIV diagnoses is consistently orders of magnitude higher than among women and heterosexual men. This indicates the presence of continued high-risk sexual behavior and signals the potential for STD and HIV acquisition.
These results have important limitations. First, MSM in this analysis included those attending STD clinics, and the results may not be generalizable to other populations of MSM. However, the high risk for HIV diagnoses among STD clinic patients suggests that this population may serve as a sentinel population for emerging disease trends and is an important population with which to intervene. Second, approximately 16% (Fig. 1 ) of the total MSM presenting for STD services at SSuN clinics were excluded because they did not have evidence of an HIV test in SSuN STD clinics, and of those who were tested for HIV, approximately 62% were tested only once. Thus, our inclusion criteria could have impacted our findings if MSM not tested for HIV in these clinics were at differential risk for HIV. If most MSM not tested for HIV in these clinics were previously positive, there would be no influence in our HIV diagnosis rates. However, if most patients are negative, it is difficult to say without more information about these patients because the bias could be in either direction. Third, patients may have had testing at an outside clinic, suggesting that our measures of new HIV diagnoses and incident STDs are minimum estimates. Fourth, our associations by demographic characteristics or STDs of interest could be impacted by other unmeasured factors. Finally, this analysis encompassed data from 2010 to 2013, and some rates or patterns in HIV acquisition may have changed since then.
Despite these limitations, our findings have important public health implications. First, these kinds of analyses are difficult to perform in smaller single jurisdictions because of small sample size. Hence, the strength of our analysis is the inclusion of multiple jurisdictions. In doing so, we are able to pool the data to estimate robust new HIV diagnosis rates. Although the majority of new HIV diagnoses in our analysis were concentrated in heavily populated jurisdictions, rates of new diagnoses among MSM in jurisdictions with much smaller MSM populations were among the highest noted. These findings are likely the result of predominately testing only those at the highest of risk presenting to STD clinics in the different jurisdictions, providing useful information for HIV prevention and care services. These data build on previous studies that some populations of MSM continue to have disproportionately higher rates of new HIV diagnoses, including young black MSM and those with a previous diagnosis of P&S syphilis, rectal chlamydia, and/or gonorrhea. However, equally important, this work demonstrates that men who are HIV uninfected and seeking STD services also are at high risk for HIV infection regardless of demographic or STD diagnoses.
